XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
23.52
-1.02 (-4.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
XOMA Royalty Market Cap
XOMA Royalty has a market cap or net worth of $277.13 million as of February 21, 2025. Its market cap has increased by 20.39% in one year.
Market Cap
277.13M
Enterprise Value
253.24M
1-Year Change
20.39%
Ranking
Category
Stock Price
$23.52
Market Cap Chart
Since December 1, 1998, XOMA Royalty's market cap has increased from $151.40M to $277.13M, an increase of 83.04%. That is a compound annual growth rate of 2.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 20, 2025 | 289.10M | -6.62% |
Dec 31, 2024 | 309.60M | 45.69% |
Dec 29, 2023 | 212.50M | 0.85% |
Dec 30, 2022 | 210.70M | -10.64% |
Dec 31, 2021 | 235.80M | -51.52% |
Dec 31, 2020 | 486.40M | 103.60% |
Dec 31, 2019 | 238.90M | 125.16% |
Dec 31, 2018 | 106.10M | -63.40% |
Dec 29, 2017 | 289.90M | 1,036.86% |
Dec 30, 2016 | 25.50M | -83.86% |
Dec 31, 2015 | 158.00M | -59.01% |
Dec 31, 2014 | 385.50M | -38.46% |
Dec 31, 2013 | 626.40M | 220.08% |
Dec 31, 2012 | 195.70M | 396.70% |
Dec 30, 2011 | 39.40M | -64.76% |
Dec 31, 2010 | 111.80M | -19.57% |
Dec 31, 2009 | 139.00M | 69.31% |
Dec 31, 2008 | 82.10M | -81.63% |
Dec 31, 2007 | 447.00M | 100.18% |
Dec 29, 2006 | 223.30M | 61.69% |
Dec 30, 2005 | 138.10M | -37.68% |
Dec 31, 2004 | 221.60M | -59.61% |
Dec 31, 2003 | 548.60M | 84.40% |
Dec 31, 2002 | 297.50M | -56.92% |
Dec 31, 2001 | 690.50M | 7.32% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |